Efficacy and Safety of Fexinidazole in Children at Least 6 Years Old and Weighing Over 20 kg With Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open Study, plug-in to the Pivotal Study
Clinical trial NCT02184689 · COMPLETED
Trial details
- NCT number
- NCT02184689
- Sponsor
- Drugs for Neglected Diseases
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-03
- Primary completion
- 2016-12-14
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.